A study that came out on May 6, 2010 says that the numbers of physicians “open” to visiting pharmaceutical reps dropped from 71% to 58%.  This has to be due, at least in part, to the relentless negative publicity that big pharma gets for its practice of sending out armies of sales reps to inform doctors about certain medications and to encourage them to prescribe them.   I have seen this trend in effect for the mental health field, among psychiatrists, mental health nurse practitioners and mental health PAs.